This transcriptional program is a major driver of elevated FA and TG synthesis in insulin-resistant states 2,12,13, subsequently leading to hepatic steatosis, increased VLDL secretion, and hypertriglyceridemia 13,19–24. The gene discussed is INS; the disease is hypertriglyceridemia.